| | Over a decade in the making, CAR T-Cell Therapy has proven to be one of the more innovative and promising treatments in oncology. Learn more about what companies should consider when it comes to this cutting edge treatment from a free white paper by TD2. |
Eli Lilly crashes out of KRAS race as toxicity sees it ditch phase 1 effort Genentech to slash nearly 500 staffers, with clinical workers hardest hit Alexion dumps ex-Achillion C3G program after seeing phase 2 data Sponsored: FROM CHOLERA TO COVID-19: How integrated data visualizations inform decisions and impact actions Novartis, Sangamo team up on genetic meds for autism in $75M deal F-star set to land Nasdaq listing through Spring Bank merger Looking beyond COVID-19's spike protein for the next wave of vaccines Sorrento picks up color-changing COVID-19 saliva test built by Columbia University fertility clinic Featured Story | By Ben Adams Eli Lilly has quietly dropped its KRAS effort in cancer, leaving the door open for its rivals. read more |
| |
|---|
|
Top Stories By Ben Adams Genentech is taking the ax to 474 staffers on the West Coast as it looks for a more local feel to its organization. read more By Nick Paul Taylor Alexion has scrapped development of the lead asset acquired in its $930 million takeover of Achillion Pharmaceuticals in one indication. The action follows a “suboptimal” clinical response in two phase 2 trials in C3 glomerulopathy (C3G) patients that were expected to support global regulatory talks. read more By PerkinElmer, Inc How integrated data visualizations inform decisions and impact actions. Data visualization was first used to recognize disease patterns in the 1854 London cholera outbreak. It is even more essential today. read more By Amirah Al Idrus Sangamo’s struck another CNS deal—this time, it’s teaming up with Novartis on neurodevelopmental disorders, including autism spectrum disorder and intellectual disability. $75 million is changing hands upfront, but Sangamo could pick up an additional $720 million in milestones over the three-year deal. read more By Nick Paul Taylor F-star Therapeutics is set to merge with Spring Bank Pharmaceuticals, giving it a Nasdaq listing to support the advance of its pipeline of bispecific antibodies. The merger comes months after a death in Spring Bank’s phase 2b hepatitis B trial torpedoed the biotech’s stock. read more By Angus Liu Most ongoing vaccine development efforts against the novel coronavirus focus on the spike protein on the surface of SARS-CoV-2. But a team led by immuno-oncology specialist TScan Therapeutics found that memory CD8+ T cells from recovered patients mainly target sites outside of the spike protein. read more By Conor Hale The single-step test aims to provide an easy-to-read result in less than 30 minutes just about anywhere. read more Resources Sponsored by: Lonza Pharma & Biotech A novel spray-dried dispersion platform has been developed to faciliate high drug load applications Sponsored by: PRA Health Sciences Collaboration across the industry will be key to meeting the demands of the RACE Act and ensuring pediatric patients receive the care and treatments they need. Sponsored by: Cambrex The industry trend of outsourcing to CDMOs continues. With more services, capabilities, facilities, and employees than ever before, our experts have contributed more articles to our biggest eBook yet. Sponsored by: EVERSANA How predictive analytics and machine learning have the potential to transform healthcare by predicting “Patient Switching Behaviors.” Sponsored by: Recro Gainesville Wurster processing is a versatile technique for developing and manufacturing multiparticulates for modified release dosage forms. Read this whitepaper to determine whether Wurster processing is the right option for your project. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. 18th Annual Discovery on Target Virtual September 16-18, 2020 Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training ongoing now. | COVID19 provisions – training will be on-site as normal. | New – may be possible for some individuals to access the training virtually in real time. | 